data_1ct6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ct6 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 74.8 m . . . . . 0 CA--C 1.549 0.934 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.72 -92.85 0.09 OUTLIER Glycine 0 N--CA 1.48 1.605 0 CA-C-O 120.065 -0.297 . . . . 0.0 112.396 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.2 -95.5 1.76 Allowed Glycine 0 N--CA 1.484 1.896 0 CA-C-O 122.658 1.143 . . . . 0.0 115.353 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.3 mm -116.19 8.93 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.555 0 CA-C-N 111.987 -2.106 . . . . 0.0 107.548 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.3 ttt180 -155.36 89.49 1.2 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.185 -1.572 . . . . 0.0 108.426 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.71 80.16 1.25 Allowed Glycine 0 N--CA 1.483 1.768 0 N-CA-C 114.36 0.504 . . . . 0.0 114.36 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.283 0.7 OUTLIER -158.91 -59.33 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.559 0.744 . . . . 0.0 111.322 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -159.48 -65.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.988 0.915 . . . . 0.0 109.528 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.521 0 CA-C-O 118.901 -0.944 . . . . 0.0 110.942 -179.862 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 43.2 t . . . . . 0 CA--C 1.552 1.032 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.81 -94.43 0.1 OUTLIER Glycine 0 N--CA 1.479 1.513 0 CA-C-O 119.635 -0.536 . . . . 0.0 112.0 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 60.35 -95.9 0.09 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 116.552 1.381 . . . . 0.0 116.552 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.7 tp -56.49 -15.92 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.202 0 CA-C-N 113.276 -1.462 . . . . 0.0 114.077 173.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -153.85 116.3 4.38 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.651 0.78 . . . . 0.0 109.263 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.91 85.74 0.16 Allowed Glycine 0 CA--C 1.545 1.911 0 N-CA-C 115.96 1.144 . . . . 0.0 115.96 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -158.43 105.63 1.89 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -158.99 98.34 1.46 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.676 0 CA-C-O 119.034 -0.87 . . . . 0.0 112.283 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 72.6 m . . . . . 0 CA--C 1.551 0.982 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.71 -118.26 0.47 Allowed Glycine 0 CA--C 1.538 1.484 0 O-C-N 122.177 -0.327 . . . . 0.0 112.376 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.45 -98.3 1.88 Allowed Glycine 0 N--CA 1.486 2.014 0 CA-C-O 123.468 1.593 . . . . 0.0 113.085 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.2 pt -125.01 -14.89 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.074 0 CA-C-N 110.958 -2.621 . . . . 0.0 108.776 174.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -162.86 116.22 1.65 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 119.934 1.243 . . . . 0.0 108.284 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.49 -106.43 0.19 Allowed Glycine 0 N--CA 1.479 1.506 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -156.22 108.9 2.61 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -150.3 94.57 2.14 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.428 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -179.922 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 46.5 t . . . . . 0 CA--C 1.552 1.033 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.24 128.18 0.93 Allowed Glycine 0 CA--C 1.54 1.597 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 58.33 -93.5 0.04 OUTLIER Glycine 0 N--CA 1.492 2.427 0 N-CA-C 116.516 1.367 . . . . 0.0 116.516 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.4 tp -55.99 -9.79 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.345 0 CA-C-N 113.149 -1.526 . . . . 0.0 114.358 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -144.64 82.92 1.7 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.29 -131.0 10.16 Favored Glycine 0 CA--C 1.546 1.99 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -159.75 107.08 1.68 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.0 mtp-105 -155.35 90.84 1.28 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 CA-C-O 119.057 -0.857 . . . . 0.0 111.509 -179.162 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 27.9 p . . . . . 0 CA--C 1.55 0.965 0 CA-C-O 120.965 0.412 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.52 162.49 30.42 Favored Glycine 0 CA--C 1.544 1.855 0 CA-C-O 121.674 0.597 . . . . 0.0 113.712 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.11 -95.5 0.17 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 124.213 0.911 . . . . 0.0 114.764 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pp -56.38 -16.95 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.084 0 CA-C-N 113.115 -1.542 . . . . 0.0 113.692 172.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -156.05 82.91 1.0 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.91 -115.89 2.33 Favored Glycine 0 N--CA 1.482 1.759 0 C-N-CA 123.203 0.43 . . . . 0.0 112.128 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -155.99 138.93 15.35 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -156.71 93.05 1.34 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.394 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -179.843 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 44.3 t . . . . . 0 CA--C 1.551 0.985 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.99 -98.8 0.12 Allowed Glycine 0 N--CA 1.479 1.512 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.24 -96.44 1.73 Allowed Glycine 0 N--CA 1.485 1.954 0 CA-C-O 122.658 1.143 . . . . 0.0 115.874 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.63 15.54 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.106 0 CA-C-N 111.824 -2.188 . . . . 0.0 109.021 175.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -151.1 86.43 1.36 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.39 -174.07 51.92 Favored Glycine 0 CA--C 1.549 2.218 0 N-CA-C 115.275 0.87 . . . . 0.0 115.275 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -153.75 114.02 3.95 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -158.29 94.29 1.28 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.425 0 CA-C-O 118.997 -0.89 . . . . 0.0 110.916 -179.948 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 121.095 0.474 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -93.62 84.3 1.06 Allowed Glycine 0 CA--C 1.543 1.801 0 C-N-CA 123.173 0.416 . . . . 0.0 113.997 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 78.09 -98.91 1.51 Allowed Glycine 0 N--CA 1.482 1.735 0 N-CA-C 118.733 2.253 . . . . 0.0 118.733 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.2 pt -117.91 25.82 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 CA-C-N 112.379 -1.911 . . . . 0.0 108.661 175.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -154.86 148.78 25.68 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.906 0.86 . . . . 0.0 111.345 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.92 111.39 3.81 Favored Glycine 0 CA--C 1.545 1.92 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.466 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -156.99 134.29 10.53 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.742 0.782 . . . . 0.0 109.164 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -156.15 92.08 1.32 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.464 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -179.678 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 71.1 m . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.33 104.84 0.19 Allowed Glycine 0 N--CA 1.479 1.504 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.53 -98.65 1.8 Allowed Glycine 0 N--CA 1.486 1.975 0 CA-C-O 123.719 1.733 . . . . 0.0 113.363 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.0 tt -126.98 -19.28 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.124 0 CA-C-N 110.346 -2.927 . . . . 0.0 108.573 174.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -153.84 -66.61 0.14 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 119.977 1.262 . . . . 0.0 110.463 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -148.88 99.41 0.2 Allowed Glycine 0 N--CA 1.481 1.686 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -156.29 103.81 2.19 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -152.71 95.72 2.03 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 CA-C-O 118.954 -0.914 . . . . 0.0 112.097 -179.938 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 85.4 m . . . . . 0 CA--C 1.552 1.031 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.39 -71.61 0.05 OUTLIER Glycine 0 N--CA 1.482 1.733 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 65.28 -153.69 50.64 Favored Glycine 0 N--CA 1.481 1.692 0 CA-C-O 122.421 1.012 . . . . 0.0 114.517 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.1 mp -54.7 -23.03 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.356 0 CA-C-N 113.601 -1.3 . . . . 0.0 112.603 174.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -156.47 120.98 4.51 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 120.632 1.56 . . . . 0.0 110.323 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.78 145.48 40.15 Favored Glycine 0 CA--C 1.548 2.142 0 N-CA-C 114.657 0.623 . . . . 0.0 114.657 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -154.71 -40.67 0.09 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -154.31 98.54 2.13 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 CA-C-O 119.077 -0.846 . . . . 0.0 112.952 -179.756 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 74.7 m . . . . . 0 CA--C 1.553 1.075 0 CA-C-O 118.749 -0.644 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.406 ' HA2' ' H ' ' A' ' 7' ' ' GLU . . . 171.77 -165.76 38.63 Favored Glycine 0 CA--C 1.544 1.847 0 CA-C-O 122.421 1.012 . . . . 0.0 114.71 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.26 -97.32 1.89 Allowed Glycine 0 N--CA 1.484 1.88 0 CA-C-O 122.427 1.015 . . . . 0.0 114.824 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.75 9.93 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.364 0 CA-C-N 112.157 -2.021 . . . . 0.0 108.499 174.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -156.99 95.47 1.51 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.698 -1.251 . . . . 0.0 108.595 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 145.83 -94.28 0.17 Allowed Glycine 0 N--CA 1.481 1.691 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.406 ' H ' ' HA2' ' A' ' 2' ' ' GLY . 39.4 tt0 -155.64 -75.5 0.1 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.282 0.633 . . . . 0.0 109.308 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -159.53 107.1 1.73 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.41 0 CA-C-O 118.938 -0.923 . . . . 0.0 110.88 -179.937 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 75.1 m . . . . . 0 CA--C 1.551 0.996 0 CA-C-O 120.743 0.306 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -156.14 -148.5 5.07 Favored Glycine 0 CA--C 1.543 1.799 0 CA-C-O 121.472 0.484 . . . . 0.0 113.267 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.7 -95.53 1.71 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-O 122.645 1.136 . . . . 0.0 114.63 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.3 tt -116.97 13.13 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.356 0 CA-C-N 111.833 -2.184 . . . . 0.0 108.873 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -152.01 86.22 1.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 125.75 114.19 1.95 Allowed Glycine 0 N--CA 1.482 1.753 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -155.59 127.26 7.38 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -156.89 95.68 1.54 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.64 0 CA-C-O 118.872 -0.96 . . . . 0.0 111.883 -179.931 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 74.8 m . . . . . 0 CA--C 1.549 0.934 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.72 -92.85 0.09 OUTLIER Glycine 0 N--CA 1.48 1.605 0 CA-C-O 120.065 -0.297 . . . . 0.0 112.396 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.2 -95.5 1.76 Allowed Glycine 0 N--CA 1.484 1.896 0 CA-C-O 122.658 1.143 . . . . 0.0 115.353 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.3 mm -116.19 8.93 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.555 0 CA-C-N 111.987 -2.106 . . . . 0.0 107.548 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.3 ttt180 -155.36 89.49 1.2 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.185 -1.572 . . . . 0.0 108.426 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.71 80.16 1.25 Allowed Glycine 0 N--CA 1.483 1.768 0 N-CA-C 114.36 0.504 . . . . 0.0 114.36 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.283 0.7 OUTLIER -158.91 -59.33 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.559 0.744 . . . . 0.0 111.322 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -159.48 -65.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.988 0.915 . . . . 0.0 109.528 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.521 0 CA-C-O 118.901 -0.944 . . . . 0.0 110.942 -179.862 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 43.2 t . . . . . 0 CA--C 1.552 1.032 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.81 -94.43 0.1 OUTLIER Glycine 0 N--CA 1.479 1.513 0 CA-C-O 119.635 -0.536 . . . . 0.0 112.0 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 60.35 -95.9 0.09 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 116.552 1.381 . . . . 0.0 116.552 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.7 tp -56.49 -15.92 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.202 0 CA-C-N 113.276 -1.462 . . . . 0.0 114.077 173.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -153.85 116.3 4.38 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.651 0.78 . . . . 0.0 109.263 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.91 85.74 0.16 Allowed Glycine 0 CA--C 1.545 1.911 0 N-CA-C 115.96 1.144 . . . . 0.0 115.96 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -158.43 105.63 1.89 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -158.99 98.34 1.46 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.676 0 CA-C-O 119.034 -0.87 . . . . 0.0 112.283 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 72.6 m . . . . . 0 CA--C 1.551 0.982 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.71 -118.26 0.47 Allowed Glycine 0 CA--C 1.538 1.484 0 O-C-N 122.177 -0.327 . . . . 0.0 112.376 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.45 -98.3 1.88 Allowed Glycine 0 N--CA 1.486 2.014 0 CA-C-O 123.468 1.593 . . . . 0.0 113.085 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.2 pt -125.01 -14.89 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.074 0 CA-C-N 110.958 -2.621 . . . . 0.0 108.776 174.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -162.86 116.22 1.65 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 119.934 1.243 . . . . 0.0 108.284 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.49 -106.43 0.19 Allowed Glycine 0 N--CA 1.479 1.506 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -156.22 108.9 2.61 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -150.3 94.57 2.14 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.428 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -179.922 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 46.5 t . . . . . 0 CA--C 1.552 1.033 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.24 128.18 0.93 Allowed Glycine 0 CA--C 1.54 1.597 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 58.33 -93.5 0.04 OUTLIER Glycine 0 N--CA 1.492 2.427 0 N-CA-C 116.516 1.367 . . . . 0.0 116.516 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.4 tp -55.99 -9.79 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.345 0 CA-C-N 113.149 -1.526 . . . . 0.0 114.358 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -144.64 82.92 1.7 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.29 -131.0 10.16 Favored Glycine 0 CA--C 1.546 1.99 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -159.75 107.08 1.68 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.0 mtp-105 -155.35 90.84 1.28 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 CA-C-O 119.057 -0.857 . . . . 0.0 111.509 -179.162 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 27.9 p . . . . . 0 CA--C 1.55 0.965 0 CA-C-O 120.965 0.412 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.52 162.49 30.42 Favored Glycine 0 CA--C 1.544 1.855 0 CA-C-O 121.674 0.597 . . . . 0.0 113.712 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.11 -95.5 0.17 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 124.213 0.911 . . . . 0.0 114.764 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pp -56.38 -16.95 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.084 0 CA-C-N 113.115 -1.542 . . . . 0.0 113.692 172.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -156.05 82.91 1.0 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.91 -115.89 2.33 Favored Glycine 0 N--CA 1.482 1.759 0 C-N-CA 123.203 0.43 . . . . 0.0 112.128 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -155.99 138.93 15.35 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -156.71 93.05 1.34 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.394 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -179.843 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 44.3 t . . . . . 0 CA--C 1.551 0.985 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.99 -98.8 0.12 Allowed Glycine 0 N--CA 1.479 1.512 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.24 -96.44 1.73 Allowed Glycine 0 N--CA 1.485 1.954 0 CA-C-O 122.658 1.143 . . . . 0.0 115.874 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.63 15.54 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.106 0 CA-C-N 111.824 -2.188 . . . . 0.0 109.021 175.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -151.1 86.43 1.36 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.39 -174.07 51.92 Favored Glycine 0 CA--C 1.549 2.218 0 N-CA-C 115.275 0.87 . . . . 0.0 115.275 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -153.75 114.02 3.95 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -158.29 94.29 1.28 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.425 0 CA-C-O 118.997 -0.89 . . . . 0.0 110.916 -179.948 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 121.095 0.474 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -93.62 84.3 1.06 Allowed Glycine 0 CA--C 1.543 1.801 0 C-N-CA 123.173 0.416 . . . . 0.0 113.997 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 78.09 -98.91 1.51 Allowed Glycine 0 N--CA 1.482 1.735 0 N-CA-C 118.733 2.253 . . . . 0.0 118.733 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.2 pt -117.91 25.82 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 CA-C-N 112.379 -1.911 . . . . 0.0 108.661 175.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -154.86 148.78 25.68 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.906 0.86 . . . . 0.0 111.345 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.92 111.39 3.81 Favored Glycine 0 CA--C 1.545 1.92 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.466 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -156.99 134.29 10.53 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.742 0.782 . . . . 0.0 109.164 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -156.15 92.08 1.32 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.464 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -179.678 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 71.1 m . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.33 104.84 0.19 Allowed Glycine 0 N--CA 1.479 1.504 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.53 -98.65 1.8 Allowed Glycine 0 N--CA 1.486 1.975 0 CA-C-O 123.719 1.733 . . . . 0.0 113.363 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.0 tt -126.98 -19.28 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.124 0 CA-C-N 110.346 -2.927 . . . . 0.0 108.573 174.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -153.84 -66.61 0.14 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 119.977 1.262 . . . . 0.0 110.463 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -148.88 99.41 0.2 Allowed Glycine 0 N--CA 1.481 1.686 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -156.29 103.81 2.19 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -152.71 95.72 2.03 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 CA-C-O 118.954 -0.914 . . . . 0.0 112.097 -179.938 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 85.4 m . . . . . 0 CA--C 1.552 1.031 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.39 -71.61 0.05 OUTLIER Glycine 0 N--CA 1.482 1.733 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 65.28 -153.69 50.64 Favored Glycine 0 N--CA 1.481 1.692 0 CA-C-O 122.421 1.012 . . . . 0.0 114.517 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.451 HD12 ' H ' ' A' ' 4' ' ' ILE . 5.1 mp -54.7 -23.03 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.356 0 CA-C-N 113.601 -1.3 . . . . 0.0 112.603 174.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -156.47 120.98 4.51 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 120.632 1.56 . . . . 0.0 110.323 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.78 145.48 40.15 Favored Glycine 0 CA--C 1.548 2.142 0 N-CA-C 114.657 0.623 . . . . 0.0 114.657 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -154.71 -40.67 0.09 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -154.31 98.54 2.13 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 CA-C-O 119.077 -0.846 . . . . 0.0 112.952 -179.756 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 74.7 m . . . . . 0 CA--C 1.553 1.075 0 CA-C-O 118.749 -0.644 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.77 -165.76 38.63 Favored Glycine 0 CA--C 1.544 1.847 0 CA-C-O 122.421 1.012 . . . . 0.0 114.71 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.26 -97.32 1.89 Allowed Glycine 0 N--CA 1.484 1.88 0 CA-C-O 122.427 1.015 . . . . 0.0 114.824 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.75 9.93 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.364 0 CA-C-N 112.157 -2.021 . . . . 0.0 108.499 174.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -156.99 95.47 1.51 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.698 -1.251 . . . . 0.0 108.595 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 145.83 -94.28 0.17 Allowed Glycine 0 N--CA 1.481 1.691 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -155.64 -75.5 0.1 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.282 0.633 . . . . 0.0 109.308 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -159.53 107.1 1.73 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.41 0 CA-C-O 118.938 -0.923 . . . . 0.0 110.88 -179.937 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 75.1 m . . . . . 0 CA--C 1.551 0.996 0 CA-C-O 120.743 0.306 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -156.14 -148.5 5.07 Favored Glycine 0 CA--C 1.543 1.799 0 CA-C-O 121.472 0.484 . . . . 0.0 113.267 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.7 -95.53 1.71 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-O 122.645 1.136 . . . . 0.0 114.63 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.3 tt -116.97 13.13 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.356 0 CA-C-N 111.833 -2.184 . . . . 0.0 108.873 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -152.01 86.22 1.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 125.75 114.19 1.95 Allowed Glycine 0 N--CA 1.482 1.753 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -155.59 127.26 7.38 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -156.89 95.68 1.54 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.64 0 CA-C-O 118.872 -0.96 . . . . 0.0 111.883 -179.931 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 74.8 m . . . . . 0 CA--C 1.549 0.934 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.72 -92.85 0.09 OUTLIER Glycine 0 N--CA 1.48 1.605 0 CA-C-O 120.065 -0.297 . . . . 0.0 112.396 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.2 -95.5 1.76 Allowed Glycine 0 N--CA 1.484 1.896 0 CA-C-O 122.658 1.143 . . . . 0.0 115.353 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.3 mm -116.19 8.93 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.555 0 CA-C-N 111.987 -2.106 . . . . 0.0 107.548 175.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 81.3 ttt180 -155.36 89.49 1.2 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.185 -1.572 . . . . 0.0 108.426 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.71 80.16 1.25 Allowed Glycine 0 N--CA 1.483 1.768 0 N-CA-C 114.36 0.504 . . . . 0.0 114.36 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . 0.283 0.7 OUTLIER -158.91 -59.33 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 123.559 0.744 . . . . 0.0 111.322 179.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -159.48 -65.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.988 0.915 . . . . 0.0 109.528 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.521 0 CA-C-O 118.901 -0.944 . . . . 0.0 110.942 -179.862 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 43.2 t . . . . . 0 CA--C 1.552 1.032 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.81 -94.43 0.1 OUTLIER Glycine 0 N--CA 1.479 1.513 0 CA-C-O 119.635 -0.536 . . . . 0.0 112.0 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 60.35 -95.9 0.09 OUTLIER Glycine 0 N--CA 1.489 2.184 0 N-CA-C 116.552 1.381 . . . . 0.0 116.552 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.7 tp -56.49 -15.92 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.202 0 CA-C-N 113.276 -1.462 . . . . 0.0 114.077 173.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -153.85 116.3 4.38 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.651 0.78 . . . . 0.0 109.263 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.91 85.74 0.16 Allowed Glycine 0 CA--C 1.545 1.911 0 N-CA-C 115.96 1.144 . . . . 0.0 115.96 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -158.43 105.63 1.89 Allowed 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -158.99 98.34 1.46 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.676 0 CA-C-O 119.034 -0.87 . . . . 0.0 112.283 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 72.6 m . . . . . 0 CA--C 1.551 0.982 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.71 -118.26 0.47 Allowed Glycine 0 CA--C 1.538 1.484 0 O-C-N 122.177 -0.327 . . . . 0.0 112.376 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.45 -98.3 1.88 Allowed Glycine 0 N--CA 1.486 2.014 0 CA-C-O 123.468 1.593 . . . . 0.0 113.085 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 35.2 pt -125.01 -14.89 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.074 0 CA-C-N 110.958 -2.621 . . . . 0.0 108.776 174.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -162.86 116.22 1.65 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 119.934 1.243 . . . . 0.0 108.284 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -167.49 -106.43 0.19 Allowed Glycine 0 N--CA 1.479 1.506 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -156.22 108.9 2.61 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -150.3 94.57 2.14 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.428 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 -179.922 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 46.5 t . . . . . 0 CA--C 1.552 1.033 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.24 128.18 0.93 Allowed Glycine 0 CA--C 1.54 1.597 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 58.33 -93.5 0.04 OUTLIER Glycine 0 N--CA 1.492 2.427 0 N-CA-C 116.516 1.367 . . . . 0.0 116.516 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.4 tp -55.99 -9.79 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.586 2.345 0 CA-C-N 113.149 -1.526 . . . . 0.0 114.358 172.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -144.64 82.92 1.7 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 85.29 -131.0 10.16 Favored Glycine 0 CA--C 1.546 1.99 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -159.75 107.08 1.68 Allowed 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.0 mtp-105 -155.35 90.84 1.28 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 CA-C-O 119.057 -0.857 . . . . 0.0 111.509 -179.162 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 27.9 p . . . . . 0 CA--C 1.55 0.965 0 CA-C-O 120.965 0.412 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -177.52 162.49 30.42 Favored Glycine 0 CA--C 1.544 1.855 0 CA-C-O 121.674 0.597 . . . . 0.0 113.712 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 64.11 -95.5 0.17 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 124.213 0.911 . . . . 0.0 114.764 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 pp -56.38 -16.95 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.084 0 CA-C-N 113.115 -1.542 . . . . 0.0 113.692 172.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -156.05 82.91 1.0 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 126.91 -115.89 2.33 Favored Glycine 0 N--CA 1.482 1.759 0 C-N-CA 123.203 0.43 . . . . 0.0 112.128 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -155.99 138.93 15.35 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -156.71 93.05 1.34 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.394 0 N-CA-C 110.719 -0.953 . . . . 0.0 110.719 -179.843 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 44.3 t . . . . . 0 CA--C 1.551 0.985 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.99 -98.8 0.12 Allowed Glycine 0 N--CA 1.479 1.512 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.24 -96.44 1.73 Allowed Glycine 0 N--CA 1.485 1.954 0 CA-C-O 122.658 1.143 . . . . 0.0 115.874 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.63 15.54 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.106 0 CA-C-N 111.824 -2.188 . . . . 0.0 109.021 175.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -151.1 86.43 1.36 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.39 -174.07 51.92 Favored Glycine 0 CA--C 1.549 2.218 0 N-CA-C 115.275 0.87 . . . . 0.0 115.275 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -153.75 114.02 3.95 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -158.29 94.29 1.28 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.425 0 CA-C-O 118.997 -0.89 . . . . 0.0 110.916 -179.948 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.478 0.974 0 CA-C-O 121.095 0.474 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -93.62 84.3 1.06 Allowed Glycine 0 CA--C 1.543 1.801 0 C-N-CA 123.173 0.416 . . . . 0.0 113.997 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 78.09 -98.91 1.51 Allowed Glycine 0 N--CA 1.482 1.735 0 N-CA-C 118.733 2.253 . . . . 0.0 118.733 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.2 pt -117.91 25.82 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 CA-C-N 112.379 -1.911 . . . . 0.0 108.661 175.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -154.86 148.78 25.68 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.906 0.86 . . . . 0.0 111.345 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -69.92 111.39 3.81 Favored Glycine 0 CA--C 1.545 1.92 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.466 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -156.99 134.29 10.53 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.742 0.782 . . . . 0.0 109.164 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -156.15 92.08 1.32 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.464 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -179.678 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 71.1 m . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.33 104.84 0.19 Allowed Glycine 0 N--CA 1.479 1.504 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.53 -98.65 1.8 Allowed Glycine 0 N--CA 1.486 1.975 0 CA-C-O 123.719 1.733 . . . . 0.0 113.363 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.0 tt -126.98 -19.28 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.124 0 CA-C-N 110.346 -2.927 . . . . 0.0 108.573 174.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.9 mtp-105 -153.84 -66.61 0.14 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 119.977 1.262 . . . . 0.0 110.463 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -148.88 99.41 0.2 Allowed Glycine 0 N--CA 1.481 1.686 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -156.29 103.81 2.19 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -152.71 95.72 2.03 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 CA-C-O 118.954 -0.914 . . . . 0.0 112.097 -179.938 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 85.4 m . . . . . 0 CA--C 1.552 1.031 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -174.39 -71.61 0.05 OUTLIER Glycine 0 N--CA 1.482 1.733 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 65.28 -153.69 50.64 Favored Glycine 0 N--CA 1.481 1.692 0 CA-C-O 122.421 1.012 . . . . 0.0 114.517 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.451 HD12 ' H ' ' A' ' 4' ' ' ILE . 5.1 mp -54.7 -23.03 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.356 0 CA-C-N 113.601 -1.3 . . . . 0.0 112.603 174.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -156.47 120.98 4.51 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 120.632 1.56 . . . . 0.0 110.323 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.78 145.48 40.15 Favored Glycine 0 CA--C 1.548 2.142 0 N-CA-C 114.657 0.623 . . . . 0.0 114.657 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -154.71 -40.67 0.09 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -154.31 98.54 2.13 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 CA-C-O 119.077 -0.846 . . . . 0.0 112.952 -179.756 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 74.7 m . . . . . 0 CA--C 1.553 1.075 0 CA-C-O 118.749 -0.644 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.77 -165.76 38.63 Favored Glycine 0 CA--C 1.544 1.847 0 CA-C-O 122.421 1.012 . . . . 0.0 114.71 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.26 -97.32 1.89 Allowed Glycine 0 N--CA 1.484 1.88 0 CA-C-O 122.427 1.015 . . . . 0.0 114.824 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -118.75 9.93 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.364 0 CA-C-N 112.157 -2.021 . . . . 0.0 108.499 174.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -156.99 95.47 1.51 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.698 -1.251 . . . . 0.0 108.595 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 145.83 -94.28 0.17 Allowed Glycine 0 N--CA 1.481 1.691 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -155.64 -75.5 0.1 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.282 0.633 . . . . 0.0 109.308 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -159.53 107.1 1.73 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.41 0 CA-C-O 118.938 -0.923 . . . . 0.0 110.88 -179.937 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 75.1 m . . . . . 0 CA--C 1.551 0.996 0 CA-C-O 120.743 0.306 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -156.14 -148.5 5.07 Favored Glycine 0 CA--C 1.543 1.799 0 CA-C-O 121.472 0.484 . . . . 0.0 113.267 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.7 -95.53 1.71 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-O 122.645 1.136 . . . . 0.0 114.63 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.3 tt -116.97 13.13 7.51 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.356 0 CA-C-N 111.833 -2.184 . . . . 0.0 108.873 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -152.01 86.22 1.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 125.75 114.19 1.95 Allowed Glycine 0 N--CA 1.482 1.753 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -155.59 127.26 7.38 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -156.89 95.68 1.54 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.64 0 CA-C-O 118.872 -0.96 . . . . 0.0 111.883 -179.931 . . . . . . . . 0 0 . 1 stop_ save_